Skip to content

Merit Medical Systems MMSI Single Reportable — Nonoperating Income Expense

Similar metrics at other companies

Axcelis Technologies logo
ACLSSingle Reportable — Nonoperating Income Expense
$2.68M-31.8%
Alumis Inc. logo
ALMSSingle Reportable — Nonoperating Income Expense
$5.36M+109%
Power Integrations logo
POWISingle Reportable — Nonoperating Income Expense
$2.47M-22.1%
LQD
LQDASingle Reportable — Nonoperating Income Expense
-$4.72M-60.5%
Scholar Rock logo
SRRKSingle Reportable — Other Nonoperating Income Expense
$3.49M+248%
Pool Corporation logo
POOLReportable — Nonoperating Income Expense
-$12.37M-10.8%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's single reportable — nonoperating income expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's single reportable — nonoperating income expense?
Merit Medical Systems (MMSI) reported single reportable — nonoperating income expense of $9.39M in Q1 2026.
What does single reportable — nonoperating income expense mean?
This metric includes financial items outside of core operations, such as interest income, interest expense, and foreign exchange gains or losses. It reflects the impact of the company's capital structure and treasury management on the segment's bottom line. Understanding these items is necessary to isolate the performance of the core medical device business from financial market fluctuations.